CHEST 2023: Reduction of asthma exacerbations following initiation of single-inhaler triple therapy in US clinical care

The CHEST 2023 Annual Meeting took place October 8–11 2023 in Honolulu, Hawai’i, United States. The meeting included over 300 educational sessions relevant for the respiratory and pulmonary fields and over 600 faculty members shared their expertise.

Balkissoon R, et al. presented a poster titled ‘Reduction of asthma exacerbations following initiation of single-inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol in US clinical care’ during the ‘Late-Breaking Insights in Pulmonary Medicine Posters’ session. This analysis showed that patients with asthma experienced a reduced rate of asthma-related exacerbations following initiation of single inhaler triple therapy indicating important benefits for patients in routine care.

Please use the link below to view the presented poster.